Literature DB >> 24439928

Combined crystalline podocytopathy and tubulopathy associated with multiple myeloma.

Shreeram Akilesh1, Astier Alem2, Roberto F Nicosia3.   

Abstract

Lymphoplasmacytic neoplasms cause a wide range of injuries to the kidney exemplified by light chain cast nephropathy and amyloidosis. Filtered paraproteins can also accumulate within kidney cells and cause direct cytotoxic injury. Rarely, paraproteins that are resistant to proteolysis can crystallize within proximal tubules and cause acute tubular injury. In contrast, accumulation of crystallized paraproteins in other kidney cells, especially podocytes, is exceptional. Here, we report the finding of crystalline inclusions within podocytes and proximal tubules in a patient who presented with a combined nephrotic syndrome and Fanconi syndrome. Further workup revealed previously unsuspected multiple myeloma and elevated serum free light chains, highlighting the protean presentation of paraprotein-mediated injuries to the kidney.
© 2013.

Entities:  

Keywords:  Collapsing glomerulopathy; Crystalline inclusions; Multiple myeloma; Podocyte

Mesh:

Substances:

Year:  2013        PMID: 24439928     DOI: 10.1016/j.humpath.2013.10.007

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

Review 1.  Myeloma light chain cast nephropathy, a review.

Authors:  Insara Jaffer Sathick; Maria Eleni Drosou; Nelson Leung
Journal:  J Nephrol       Date:  2018-05-05       Impact factor: 3.902

2.  Light Chain Proximal Tubulopathy: Clinical and Pathologic Characteristics in the Modern Treatment Era.

Authors:  Michael B Stokes; Anthony M Valeri; Leal Herlitz; Abdullah M Khan; David S Siegel; Glen S Markowitz; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2015-09-15       Impact factor: 10.121

3.  Crystal-induced collapsing podocytopathy and light chain proximal tubulopathy in monoclonal gammopathy of renal significance.

Authors:  George Terinte-Balcan; Gabriel Stefan; Simona Stancu; Suxia Wang; Mihaela Gherghiceanu
Journal:  J Nephrol       Date:  2022-06-10       Impact factor: 4.393

Review 4.  Light Chain Cast Nephropathy in Multiple Myeloma: Prevalence, Impact and Management Challenges.

Authors:  Paolo Menè; Antonella Stoppacciaro; Silvia Lai; Francescaromana Festuccia
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-05-13

Review 5.  Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review.

Authors:  Xiao-Juan Yu; Xu-Jie Zhou; Su-Xia Wang; Fu-de Zhou; Ming-Hui Zhao
Journal:  BMC Nephrol       Date:  2018-11-12       Impact factor: 2.388

6.  Crystalloid podocytopathy with focal segmental glomerulosclerosis in PCM: a case report.

Authors:  You La Jeon; Woo In Lee; Yujin Choi; So Young Kang; Myeong Hee Kim; Sung-Jig Lim; Sang Ho Lee
Journal:  Diagn Pathol       Date:  2015-12-16       Impact factor: 2.644

7.  Crystalline podocytopathy and tubulopathy without overt glomerular proteinuria in a patient with multiple myeloma.

Authors:  Eun Jeong Lee; Su Yeon Lee; So Young Park; Yonjin Kim; Jae Shin Choi; Mi Jeoung Kim; Ji Hyeon Park; Jung Eun Lee; Ghee Young Kwon; Yoon-Goo Kim
Journal:  Kidney Res Clin Pract       Date:  2016-06-18

8.  Crystalline light chain proximal tubulopathy and podocytopathy: a case report.

Authors:  Ankit B Patel; John Y Choi; Walter P Mutter; Astrid Weins; Leonardo V Riella
Journal:  J Bras Nefrol       Date:  2019-12-02

9.  A case report of crystalline light chain inclusion-associated kidney disease affecting podocytes but without Fanconi syndrome: A clonal analysis of pathological monoclonal light chain.

Authors:  Kiyoaki Ito; Satoshi Hara; Kazunori Yamada; Takeshi Zoshima; Ichiro Mizushima; Hiroshi Fujii; Ryoichi Miyazaki; Yasukazu Kawai; Akihiro Yachie; Michio Nagata; Shozo Izui; Masakazu Yamagishi; Mitsuhiro Kawano
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

10.  Light Chain Crystal Podocytopathy in a Patient With Systemic Indolent B-Cell Lymphoma.

Authors:  Fareed Kamar; Melvin Silverman; Rohan John; Christopher T Chan; Anca Prica; Abhijat Kitchlu
Journal:  Kidney Int Rep       Date:  2019-12-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.